ArticleAccounts of chemical research2025
Synthesis through C(sp
Article in Accounts of chemical research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Iron-Catalyzed Dealkenylative Borylation of Alkenes via Ozonolysis.Journal of the American Chemical Society · 2026Article
- Diverse radical transformations of allenic C(sp)-C(spNature communications · 2026Article
- Total Synthesis of (-)-Neocucurbol C Enabled by Pattern Recognition and MHAT Cyclization.Journal of the American Chemical Society · 2025Article
- Alkene Diversification through a Molecular Recasting Strategy Enabled byResearch (Washington, D.C.) · 2025Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
Abstract
ConspectusThe homolytic cleavage of C-C bonds adjacent to functional groups has recently become a popular strategy for restructuring the skeletons of complex organic molecules. In contrast to the traditional reactivity profiles of polar bond disconnections, homolytic scission furnishes carbon-centered free radicals primed for controlled termination with a diverse range of radicophiles. Beyond standard radical capture, transition-metal catalysis facilitates sophisticated C-C and C-heteroatom bond-forming reactions. Intensive efforts have been focused over many years into the cleavage of the neighboring C-C bonds of carboxylic acids and alcohols. Despite the ubiquity of alkenes and ketones in natural products, feedstock chemicals, and common synthetic intermediates, much less attention has been paid to exploiting their potential in diversifying chiral pool materials, such as terpenes and terpenoids. Defunctionalization in this manner is a powerful approach for synthesizing high-value chemicals and advanced synthetic intermediates because of the possibility to reconstruct and further decorate chirality-bearing carbon skeletons. Motivated by synthetic necessity, since 2018 our group has focused on developing ozonolysis-based dealkenylative molecular diversification, and we expanded into deacylation in 2025. In this Account, we chronicle our initial motivation, describe the historical background, and summarize our research into dealkenylative and deacylative synthesis. Our dealkenylative approach capitalizes on the ozonolysis of alkenes in MeOH to generate α-methoxyhydroperoxides primed for a reaction with reducing agents. Their reduction through single electron transfer, mediated by a transition metal, leads to the formation of an alkoxyl radical that undergoes rapid β-scission, furnishing both a carbon-centered free radical and an ester group derived from the acetal carbon atom. The produced free radical can be strategically terminated by radicophiles, thereby delivering remodeled chiral molecules. Using this concept, we have developed hydrodealkenylation (through hydrogen atom transfer from benzenethiol), dealkenylative thiylation (through thiyl group transfer from diaryl disulfides), alkenylation (through addition/elimination with nitrostyrenes), and oxodealkenylation (through treatment with TEMPO followed by oxidation). Furthermore, kinetic analysis has enabled the development of a catalytic Fe
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.